BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 11156958)

  • 21. SU5416 does not attenuate early RV angiogenesis in the murine chronic hypoxia PH model.
    Peloquin GL; Johnston L; Damarla M; Damico RL; Hassoun PM; Kolb TM
    Respir Res; 2019 Jun; 20(1):123. PubMed ID: 31208454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor receptor inhibitor enhances dietary salt-induced hypertension in Sprague-Dawley rats.
    Gu JW; Manning RD; Young E; Shparago M; Sartin B; Bailey AP
    Am J Physiol Regul Integr Comp Physiol; 2009 Jul; 297(1):R142-8. PubMed ID: 19420288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Key role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in pulmonary vascular remodeling and vascular angiogenesis associated with hypoxic pulmonary hypertension.
    Ma C; Li Y; Ma J; Liu Y; Li Q; Niu S; Shen Z; Zhang L; Pan Z; Zhu D
    Hypertension; 2011 Oct; 58(4):679-88. PubMed ID: 21859965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent.
    Mendel DB; Laird AD; Smolich BD; Blake RA; Liang C; Hannah AL; Shaheen RM; Ellis LM; Weitman S; Shawver LK; Cherrington JM
    Anticancer Drug Des; 2000 Feb; 15(1):29-41. PubMed ID: 10888034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade.
    Tuder RM; Zhen L; Cho CY; Taraseviciene-Stewart L; Kasahara Y; Salvemini D; Voelkel NF; Flores SC
    Am J Respir Cell Mol Biol; 2003 Jul; 29(1):88-97. PubMed ID: 12600822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lung overexpression of angiostatin aggravates pulmonary hypertension in chronically hypoxic mice.
    Pascaud MA; Griscelli F; Raoul W; Marcos E; Opolon P; Raffestin B; Perricaudet M; Adnot S; Eddahibi S
    Am J Respir Cell Mol Biol; 2003 Oct; 29(4):449-57. PubMed ID: 12714372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactive oxygen species induced Ca
    Suresh K; Servinsky L; Jiang H; Bigham Z; Yun X; Kliment C; Huetsch J; Damarla M; Shimoda LA
    Am J Physiol Lung Cell Mol Physiol; 2018 May; 314(5):L893-L907. PubMed ID: 29388466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel rat model of pulmonary hypertension induced by mono treatment with SU5416.
    Chen Y; Kuang M; Liu S; Hou C; Duan X; Yang K; He W; Liao J; Zheng Q; Zou G; Chen H; Yan H; Chen J; Li Y; Zhou Y; Luo X; Jiang Q; Tang H; Lu W; Wang J
    Hypertens Res; 2020 Aug; 43(8):754-764. PubMed ID: 32472112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor receptor blockade by SU5416 combined with pulsatile shear stress causes apoptosis and subsequent proliferation of apoptosis-resistant endothelial cells.
    Sakao S; Taraseviciene-Stewart L; Lee JD; Wood K; Cool CD; Voelkel NF
    Chest; 2005 Dec; 128(6 Suppl):610S-611S. PubMed ID: 16373861
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growth.
    Hess C; Vuong V; Hegyi I; Riesterer O; Wood J; Fabbro D; Glanzmann C; Bodis S; Pruschy M
    Br J Cancer; 2001 Dec; 85(12):2010-6. PubMed ID: 11747347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.
    Voelkel NF; Tuder RM; Wade K; Höper M; Lepley RA; Goulet JL; Koller BH; Fitzpatrick F
    J Clin Invest; 1996 Jun; 97(11):2491-8. PubMed ID: 8647941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in rats.
    Roman CD; Choy H; Nanney L; Riordan C; Parman K; Johnson D; Beauchamp RD
    J Surg Res; 2002 Jun; 105(1):43-7. PubMed ID: 12069500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction and Characterization of Pulmonary Hypertension in Mice using the Hypoxia/SU5416 Model.
    Bikou O; Hajjar RJ; Hadri L; Sassi Y
    J Vis Exp; 2020 Jun; (160):. PubMed ID: 32568218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bortezomib alleviates experimental pulmonary arterial hypertension.
    Kim SY; Lee JH; Huh JW; Kim HJ; Park MK; Ro JY; Oh YM; Lee SD; Lee YS
    Am J Respir Cell Mol Biol; 2012 Nov; 47(5):698-708. PubMed ID: 22842494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy.
    Geng L; Donnelly E; McMahon G; Lin PC; Sierra-Rivera E; Oshinka H; Hallahan DE
    Cancer Res; 2001 Mar; 61(6):2413-9. PubMed ID: 11289107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of angiogenesis by blocking activation of the vascular endothelial growth factor receptor 2 leads to decreased growth of neurogenic sarcomas.
    Angelov L; Salhia B; Roncari L; McMahon G; Guha A
    Cancer Res; 1999 Nov; 59(21):5536-41. PubMed ID: 10554031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension.
    Taraseviciene-Stewart L; Scerbavicius R; Choe KH; Cool C; Wood K; Tuder RM; Burns N; Kasper M; Voelkel NF
    Am J Physiol Lung Cell Mol Physiol; 2006 Oct; 291(4):L668-76. PubMed ID: 16698853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amiloride analogs inhibit chronic hypoxic pulmonary hypertension.
    Quinn DA; Du HK; Thompson BT; Hales CA
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1263-8. PubMed ID: 9563749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remodelling of the pulmonary arteries during recovery from pulmonary hypertension induced by neonatal hypoxia.
    Hall SM; Hislop AA; Wu Z; Haworth SG
    J Pathol; 2004 May; 203(1):575-83. PubMed ID: 15095481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.